Qiagen N.V. (QGEN) News

Qiagen N.V. (QGEN): $41.65

0.57 (+1.39%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

B

Filter QGEN News Items

QGEN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

QGEN News Highlights

  • For QGEN, its 30 day story count is now at 2.
  • Over the past 15 days, the trend for QGEN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • NGS are the most mentioned tickers in articles about QGEN.

Latest QGEN News From Around the Web

Below are the latest news stories about QIAGEN NV that investors may wish to consider to help them evaluate QGEN as an investment opportunity.

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

Investors remain optimistic about QIAGEN (QGEN), backed by strategic alliances and potential in the Molecular Diagnostics arena.

Yahoo | December 28, 2023

QIAGEN's (QGEN) Strategic Alliances Aid Amid Macro Woes

QIAGEN (QGEN) aims to expand the NGS platform by rapidly scaling up the new Enterprise Genomics Services.

Yahoo | December 13, 2023

Estimating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)

Key Insights The projected fair value for Qiagen is US$36.75 based on 2 Stage Free Cash Flow to Equity Current share...

Yahoo | December 4, 2023

Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?

Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 1, 2023

DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy

QIAGEN’s ForenSeq Kintelligence System recently used by DNA Labs International in the U.S. to solve unidentified remains case in Oregon and 51-year-old criminal investigation in Georgia // ForenSeq Kintelligence enables identification of distant relatives in genealogy databases, helping to resolve previously unsolvable cases and bringing answers to victims and families // DNA Labs International is one of the first labs to offer this new approach to human identificationVenlo, the Netherlands, and

Yahoo | November 30, 2023

Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report?

Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | November 30, 2023

Qiagen (QGEN) Up 9.9% Since Last Earnings Report: Can It Continue?

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | November 29, 2023

QIAGEN (QGEN) Expands Sample Technologies Line With New Launch

QIAGEN's (QGEN) latest launches will better address the special needs of researchers working with challenging samples, allowing them to work more efficiently.

Yahoo | November 16, 2023

QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation

TissueLyser III bead mill instrument can be used to effectively disrupt samples such as bones, as well as animal and plant tissue to enable access to nucleic acids // TissueLyser III enhances QIAGEN portfolio for high-throughput sample preparation // RNeasy PowerMax Soil Pro Kit compatible with TissueLyser III, utilizes advanced Inhibitor Removal Technology for challenging soil samples as part of a streamlined workflowVenlo, the Netherlands, Nov. 15, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN;

Yahoo | November 15, 2023

QIAGEN (QGEN) Launches QIAcuity Kits and Software Update

QIAGEN's (QGEN) new QIAcuity kits are likely to expand application areas and foster digital PCR adoption.

Yahoo | November 15, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!